Grünenthal Meds
Jennifer Bteich has a diverse and extensive background in pharmaceuticals, with experience ranging from medical representative to regional franchise head. She has held various roles in marketing and sales, specializing in rare diseases, immunology, and hepatology. Jennifer has demonstrated success in managing key accounts, launching new products, and implementing strategic initiatives to drive commercial success. She currently serves as an Associate Director at Grünenthal Meds and has previously worked at Kyowa Kirin International plc., NewBridge Pharmaceuticals, and Pfizer. Jennifer holds a Bachelor of Pharmacy degree from Lebanese American University.
This person is not in any offices
Grünenthal Meds
1 followers
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.